This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: 23Andme, Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: The Innovative Contributions of Dominic Samuel Berns
Introduction
Dominic Samuel Berns is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of medical science, particularly in the treatment of asthma. With a total of 2 patents to his name, Berns is recognized for his innovative approaches to addressing complex health issues.
Latest Patents
Berns' latest patents focus on methods of treating asthma using anti-IL1RAP antibodies. The first patent presents binding proteins, such as antibodies and antigen-binding fragments, which specifically bind to human interleukin-1 receptor accessory protein (hu-IL1RAP). This invention aims to fully block the IL-1, IL-33, and IL-36 intracellular signaling pathways. The second patent reiterates this concept, providing compositions comprising such binding proteins and methods of making and using them.
Career Highlights
Dominic Berns is currently employed at 23andMe, Inc., where he continues to develop innovative solutions in the field of biotechnology. His work is instrumental in advancing the understanding and treatment of various medical conditions.
Collaborations
Berns collaborates with talented individuals such as Davide Foletti and Erik E Karrer, contributing to a dynamic and innovative work environment.
Conclusion
Dominic Samuel Berns exemplifies the spirit of innovation in the medical field through his patents and contributions at 23andMe, Inc. His work in developing treatments for asthma showcases the potential of scientific research to improve health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile